Frontiers in Anti-infective Drug Discovery

Volume 2

by

Atta-ur-Rahman, M. Iqbal Choudhary

DOI: 10.2174/97816080586001140201
eISBN: 978-1-60805-860-0, 2014
ISBN: 978-1-60805-861-7
ISSN: 1879-663X (Print)



Recommend this eBook to your Library

Indexed in: Chemical Abstracts, Scopus, EMBASE

“Frontiers in Anti-Infective Drug Discovery” is an Ebook series devoted to publ...[view complete introduction]

Table of Contents

Preface

- Pp. i-ii (2)

Atta-ur-Rahman

Download Free

List of Contributors

- Pp. iii-iv (2)

Atta-ur-Rahman

Download Free

Marine Red Algae as Source of Bioactive Therapeutic Molecules with Activity Against Viral Infection

- Pp. 3-85 (83)

Silvia Novío, María Jesús Núñez and Manuel Freire-Garabal

View Abstract Purchase Chapter

Development of Synthetic Antimicrobial Peptides as Therapeutic Agents to Treat Drug Resistant Bacterial and Fungal Infections

- Pp. 86-158 (73)

Rickey P. Hicks and Tiffany D. Clark

View Abstract Purchase Chapter

Natural Products as Anti-Infective Agents

- Pp. 159-223 (65)

Sidharth Chopra, Ellen D. Beaulieu and Jeremiah P. Malerich

View Abstract Purchase Chapter

Targeting the Molecular Basis of Resistance

- Pp. 224-268 (45)

Samar A.M. Salem and Nehal M. Zuel-Fakkar

View Abstract Purchase Chapter

Anti-Malaria Chemotherapy: State-of-the-Art in Prevention and Treatment and Novel Leads for Drug Development

- Pp. 269-397 (129)

Ana Maria Madeira M. Faísca Phillips

View Abstract Purchase Chapter

Index

- Pp. 398-410 (13)

Atta-ur-Rahman and M. Iqbal Choudhary

Download Free

Preface

Infections caused by viruses, bacteria, fungi and parasites are enduring threats to human well-being and survival. The discovery of antibiotics in 1928 had given the hope of controlling infectious diseases to human, livestocks and plants. However, wide spread and rapid emergence of multidrug resistance (MDR) in viruses and microorganisms, as well as their vectors, has posed a major challenge to the healthcare sector, creating a fear of return of the pre-antibiotic period. The emergence of MDR microorganisms and lack of effective antibiotics against them has direct impact on every sector of healthcare, including success of surgical interventions, post-surgical survival, neonatal and elderly care, etc. Unfortunately major pharmaceutical conglomerates have either closed down or downsized their anti-infectious drug discovery programs. Similarly, the number of academic researchers working on the anti-infectives agents has also reduced over he years. Ironically our understanding of infection in general, and spontaneous and acquired resistance in pathogens in particular at genetic and molecular levels, has improved substantially during the same period.

The volume entitled “Frontiers in Anti-Infective Drug Discovery” is our effort to highlight the continuous importance of research in this field. The volume contains five excellent articles by leading researchers in the field. These articles not only cover discoveries of anti-infective agents of natural and synthetic origins, but also review scientific work on the identification of molecular targets for new anti-infectious agents.

The article contributed by Novio et al reviews the literature on antiviral properties of marine natural products, mainly from algal sources. The viruses targeted include HIV, herpes simplex, influenza and cytomegalovirus viruses.

Peptides have been known to possess a variety of biological activities, including antibacterial and cytotoxic properties. Hick and Clark have contributed a comprehensive review on the activity of synthetic peptides against the multidrug resistance bacteria and fungi, known to cause a variety of infections. Physicochemical properties concerning of peptide-cell wall lipid interactions of therapeutically important peptides, their mechanisms of action, as well as methods to overcome the problems associated with the therapeutic use natural and synthetic peptides (metabolic stability, lack of selectivity and stability, etc.) are also discussed.

Chopra et al in their review focus on the diverse scaffolds of natural products and their anti-infective properties. These natural inhibitors provide excellent leads for further development. The advent of enabling technologies for the dereplication, isolation and structure determination of natural products, as well as the development of new biological screening methods, have further accelerated the process of discovery of new anti-infective agents from natural sources.

The understanding the multidrug resistance the mechanisms molecular level is the key to modern drug discovery and development against pathogenic agents. Salem and Zuel-Fakkar have reviewed the recent developments in the fields of molecular and structural biology and molecular genetics, related to intrinsic and acquired resistance in microorganisms, against available drugs. These complex molecular processes help us to understand the mechanisms of inhibition and to identify the targets for development of the next generations of antibiotics and MDR reversal agents.

Last but not least, Maderia and Phillips have reviewed the recent scientific work on the prevention and treatment of malaria through anti-malarial chemotherapies. Malaria being the major killer of human race, particularly in developing countries, remains a gigantic healthcare challenge for national governments and for pharmaceutical and biomedical R&D scientists. The development of new leads for malarial prevention and treatment is focused in this review.

We are confident that these contributions by experienced researchers will not only help the readers in developing a better understanding of the science behind anti-infection drug discovery and development, but most importantly will highlight the importance of systematic and sustainable efforts in this area. We are grateful to all the contributors for their diligent efforts in reviewing the recent literature on various aspects of the field in comprehensive and timely manner. We also acknowledge the efforts and hard work of the editorial team, particularly Mr. Mahmood Alam (Director Publication) and Miss. Hira Aftab (Assistant Manager) of Bentham Science Publishers.

Dr. Atta-ur-Rahman, FRS
Dr. M. Iqbal Choudhary
2013, Karachi, Pakistan

List of Contributors

Editor(s):
Prof Atta-ur-Rahman
University of Cambridge
UK


Prof. M. Iqbal Choudhary
H.E.J. Research Institute of Chemistry
International Center for Chemical and Biological Sciences
University of Karachi
Pakistan




Contributor(s):
Sidharth Chopra
Central Drug Research Institute
Lucknow
UP


Ellen D. Beaulieu
SRI International
Biosciences Division
Menlo Park
CA
USA


Jeremiah P. Malerich
SRI International
Biosciences Division
Menlo Park
CA
USA


Silvia Novío
Department of Pharmacology
Lennart Levi Stress and Neuroimmunology Laboratory
School of Medicine
C/ San Francisco s/n
Santiago de Compostela , 15782
Spain


María Jesús Núñez
Department of Pharmacology
Lennart Levi Stress and Neuroimmunology Laboratory
School of Medicine
C/ San Francisco s/n
15782 Santiago de Compostela
Spain


Manuel Freire-Garabal
Department of Pharmacology
Lennart Levi Stress and Neuroimmunology Laboratory
School of Medicine
C/ San Francisco s/n
Santiago de Compostela , 15782
Spain


Rickey P. Hicks
Department of Chemistry
East Carolina University
Greenville
NC , 27858
United States


Tiffany D. Clark
Department of Chemistry
East Carolina University
Greenville
NC , 27858
United States


Ana Maria Madeira M. Faísca Phillips
Department of Chemistry
Faculty of Sciences and Technology
Universidade Nova de Lisboa
Campus de Caparica
Quinta da Torre
Caparica, 2829-516
Portugal


Samar Abdallah M. Salem
Dermatology, Venereology and Anderology Department
Faculty of Medicine
Ain Shams University
Cairo
Egypt


Nehal M. Zuel-Fakkar
Dermatology, Venereology and Anderology Department
Faculty of Medicine
Ain Shams University
Cairo
Egypt




Advertisement


Related Journals



Related Books



Webmaster Contact: urooj@benthamscience.org Copyright © 2016 Bentham Science